Robotti Robert decreased its stake in Cavco Inds Inc Del (CVCO) by 16.92% based on its latest 2017Q3 regulatory filing with the SEC. Robotti Robert sold 29,230 shares as the company’s stock declined 2.45% while stock markets rallied. The institutional investor held 143,493 shares of the basic industries company at the end of 2017Q3, valued at $21.17 million, down from 172,723 at the end of the previous reported quarter. Robotti Robert who had been investing in Cavco Inds Inc Del for a number of months, seems to be less bullish one the $1.50B market cap company. The stock increased 3.83% or $6.1 during the last trading session, reaching $165.5. About 92,148 shares traded or 110.76% up from the average. Cavco Industries, Inc. (NASDAQ:CVCO) has risen 19.38% since February 13, 2017 and is uptrending. It has outperformed by 2.68% the S&P500.
683 Capital Management Llc decreased its stake in Durect Corp (DRRX) by 38.09% based on its latest 2017Q3 regulatory filing with the SEC. 683 Capital Management Llc sold 815,144 shares as the company’s stock rose 21.78% with the market. The hedge fund held 1.32M shares of the major pharmaceuticals company at the end of 2017Q3, valued at $2.35M, down from 2.14 million at the end of the previous reported quarter. 683 Capital Management Llc who had been investing in Durect Corp for a number of months, seems to be less bullish one the $161.92M market cap company. It closed at $1.09 lastly. It is down 7.89% since February 13, 2017 and is uptrending. It has underperformed by 8.81% the S&P500.
Investors sentiment decreased to 1.45 in 2017 Q3. Its down 0.15, from 1.6 in 2017Q2. It turned negative, as 12 investors sold CVCO shares while 39 reduced holdings. 22 funds opened positions while 52 raised stakes. 7.99 million shares or 1.12% less from 8.08 million shares in 2017Q2 were reported. Federated Invsts Inc Pa holds 0% of its portfolio in Cavco Industries, Inc. (NASDAQ:CVCO) for 119 shares. The Germany-based Deutsche National Bank & Trust Ag has invested 0% in Cavco Industries, Inc. (NASDAQ:CVCO). Goldman Sachs Gru Incorporated accumulated 0% or 13,013 shares. Great West Life Assurance Can invested 0% of its portfolio in Cavco Industries, Inc. (NASDAQ:CVCO). Pier Capital has 0.51% invested in Cavco Industries, Inc. (NASDAQ:CVCO) for 20,059 shares. Credit Suisse Ag reported 10,508 shares. Regions Financial has 0% invested in Cavco Industries, Inc. (NASDAQ:CVCO) for 1,433 shares. Parkside Retail Bank Tru holds 5 shares or 0% of its portfolio. Zurcher Kantonalbank (Zurich Cantonalbank) holds 489 shares. State Street reported 0% stake. Fincl Bank Of America De owns 13,069 shares. Investors has 0.01% invested in Cavco Industries, Inc. (NASDAQ:CVCO) for 204,000 shares. Anchor Capital Advsr Ltd Liability accumulated 19,545 shares. Aqr Capital Mgmt Ltd Limited Liability Company holds 0% or 6,214 shares. California-based Schwab Charles Invest Mgmt has invested 0% in Cavco Industries, Inc. (NASDAQ:CVCO).
Robotti Robert, which manages about $364.54M US Long portfolio, upped its stake in Atwood Oceanics Inc (NYSE:ATW) by 106,985 shares to 1.29M shares, valued at $12.10M in 2017Q3, according to the filing. It also increased its holding in Dawson Geophysical Co (TGE) by 200,000 shares in the quarter, for a total of 222,845 shares, and has risen its stake in Lsb Inds Inc (NYSE:LXU).
Since September 19, 2017, it had 0 buys, and 2 selling transactions for $840,904 activity. On Tuesday, September 19 the insider Greenblatt David A. sold $410,043.
Among 3 analysts covering Durect (NASDAQ:DRRX), 1 have Buy rating, 0 Sell and 2 Hold. Therefore 33% are positive. Durect had 6 analyst reports since April 25, 2016 according to SRatingsIntel. As per Friday, October 20, the company rating was downgraded by Stifel Nicolaus. The stock of DURECT Corporation (NASDAQ:DRRX) has “Neutral” rating given on Friday, October 20 by H.C. Wainwright. H.C. Wainwright maintained DURECT Corporation (NASDAQ:DRRX) on Friday, June 23 with “Buy” rating. H.C. Wainwright initiated DURECT Corporation (NASDAQ:DRRX) rating on Monday, August 14. H.C. Wainwright has “Buy” rating and $300 target. On Wednesday, July 12 the stock rating was upgraded by Stifel Nicolaus to “Buy”. As per Monday, April 25, the company rating was initiated by Rodman & Renshaw.
Investors sentiment increased to 2.05 in Q3 2017. Its up 0.57, from 1.48 in 2017Q2. It is positive, as 6 investors sold DRRX shares while 16 reduced holdings. 18 funds opened positions while 27 raised stakes. 65.27 million shares or 3.59% more from 63.01 million shares in 2017Q2 were reported. Blume Mngmt Incorporated stated it has 6,000 shares or 0.01% of all its holdings. Mangrove, a New York-based fund reported 1.27 million shares. 255,000 were accumulated by Zazove Ltd Liability Company. Goldman Sachs Grp owns 0% invested in DURECT Corporation (NASDAQ:DRRX) for 66,347 shares. Vanguard Group Incorporated owns 6.01M shares for 0% of their portfolio. Ameritas Invest Ptnrs Inc accumulated 8,677 shares. One Trading Lp reported 0% in DURECT Corporation (NASDAQ:DRRX). Meeder Asset Mngmt Inc accumulated 1,274 shares. Virtu Fincl Llc has 11,076 shares. Metropolitan Life Communication Ny owns 95,663 shares. Tocqueville Asset Management Lp invested in 2.04 million shares. Citadel Advsrs Lc invested in 0% or 38,688 shares. Gagnon Secs Ltd Liability Company invested in 0.79% or 1.25M shares. Bruce Inc, Illinois-based fund reported 488,112 shares. Ameriprise Finance holds 201,772 shares or 0% of its portfolio.
683 Capital Management Llc, which manages about $566.08M and $951.63M US Long portfolio, upped its stake in Procter And Gamble Co (Put) (NYSE:PG) by 100,000 shares to 300,000 shares, valued at $27.29 million in 2017Q3, according to the filing. It also increased its holding in Adient Plc by 33,015 shares in the quarter, for a total of 543,015 shares, and has risen its stake in Aldeyra Therapeutics Inc (NASDAQ:ALDX).
Analysts await DURECT Corporation (NASDAQ:DRRX) to report earnings on March, 13. They expect $-0.05 earnings per share, up 16.67% or $0.01 from last year’s $-0.06 per share. After $0.04 actual earnings per share reported by DURECT Corporation for the previous quarter, Wall Street now forecasts -225.00% negative EPS growth.